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Abstract
A short synthesis of the postulated structure for indolizidine alkaloid 259B with the hydrogens at C5 and C9 entgegen has been
achieved with complete control of stereochemistry at C5. Both diastereoisomers at C8 were obtained, but neither proved to be the
natural product. The comparison of the mass and FTIR spectral properties of the synthetic compounds to those of the natural
material strongly suggest that the gross structure is correct and that the difference may be a branch in the C5 alkyl side-chain. The
GC-retention times of the two synthetic compounds were markedly longer than that of the natural 5,9E-259B.
Background
Indolizidines are common in nature [1] and to date over eighty
5,8-disubstituted indolizidine alkaloids have been isolated from
the skins of frogs [2]. Due to the scarcity of such indolizidine
alkaloids from the natural sources, for the most part the biolo-
gical  properties  of  these  materials  have  not  been  fully
evaluated. However,  synthetic 5,8-disubstituted indolizidine
5,9Z-235B' (Figure 1), has recently been shown to be a potent
and  selective  non-competitive  inhibitor  of  nicotinic  acet-
ylcholine receptors [3]. Earlier work had reported that indoliz-
idines 5,9Z-203A  and 5,9Z-235B'  (Figure 1), and other 5,8-
disubstituted indolizidines were non-competitive blockers of
the ganglionic subtype of nicotinic receptors [4]. For most of
the  5,8-disubstituted  indolizidines  the  structures  have  been
assigned  by  a  combination  of  GC-mass  spectrometry  and
GC-FTIR  spectroscopy  [2]  and  such  structures  must  be
considered  tentative  until  NMR  studies  on  isolated  pure
compounds can be obtained or until synthetic material is avail-
able for comparison. In the EI-mass spectrum of 5,8-disubsti-
tuted indolizidines loss of the C5 chain gives rise to the base
peak, identifying the mass of the C5 substituent. The resulting
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Scheme 1: Reagents: (i) MeMgI. 96% (ii) PTSA 71%. (iii) TiCl4 CH2Cl2 25 oC 3d 68%. (iv) MsCl, Et3N, THF -40 oC, 74%. (v) Grubbs' catalyst, 25 oC
CH2Cl2, 90%. (vi) H2 MeOH Pt/C 79%. (vii) LiAlH4, AlCl3, 73%. (viii) (a) Dess Martin periodinane, 77%. (b) Ph3P+CH2I I-, NaN(SiMe3)2 51%. (c) TMS
acetylene, CuI, Pd(Ph3P)3, Et3N then K2CO3 MeOH, 69%.
cation undergoes a retro Diels-Alder fragmentation losing an
alkene thus identifying the mass of the C8 substituent. Once the
gross structure has been assigned, analysis of the vapor-phase
infrared spectrum, particularly the Bohlmann bands,  allows
assignment of the relative configuration of the chiral centres at
C5 and C9. When the two hydrogens on C5 and C9 are both
axial (trans anti-parallel to the N lone pair), designated as 5,9Z
(Figure 1), the presence of a strong, sharp Bohlmann band at
approximately 2789 cm−1 confirms this relative configuration.
In the alternative diastereoisomer when one hydrogen is axial
and the other  equatorial,  designated as  5,9E,  the  Bohlmann
band is weak and is shifted to 2810 cm−1. Most 5,8-disubsti-
tuted indolizidines detected in frog skin extracts have the 5,9Z
relative configuration, with 259B being very unusual in that it
has the 5,9E relative configuration. Not surprisingly then, with
the exception of the synthesis of two 5,9E diastereomers of the
natural 5,9Z-223V  [5], most of the synthetic effort has been
directed towards the 5,9Z  isomers and this has resulted in a
large  number  of  elegant  approaches  to  these  indolizidines
[6-35].
Results and Discussion
The  absolute  configurations  of  5,9Z-203A  and  5,9Z-235B'
(Figure 1) and several other such 5,9Z indolizidines are known
[2]. Thus, in analogy to such 5,9Z indolizidines it might be anti-
cipated that for the 5,9E indolizidines the stereochemistry at C9
will also be R. We now report an enantioselective synthesis of
the  tentative  structure  postulated  for  ent-indolizidine  5,9E-
259B, which is outlined in Scheme 1 using (S)-pyroglutamic
acid as the chiral starting material. The synthesis is extremely
short, robust, does not utilise any protecting groups, appears to
be completely diastereoselective at C5 and gives both diaste-
reoisomers at C8.
Figure 1: Subclasses of diastereoisomeric 5,8-disubstituted alkaloids.
The absolute stereochemistry of 5,9Z-203A and 5,9Z-235B' are as
shown, while the structure shown for 5,9E-259B is tentative as postu-
lated based on mass and FTIR spectra [2]. Almost all of the 5,8-disub-
stituted indolizidines detected in frog skin extracts have proved to be
the 5,9Z isomers [2].
Reaction of (S)-ethylpyroglutamate with an excess of methyl
magnesium iodide gave the water soluble tertiary alcohol 1 in
96% yield. 7-Oxoheptanoic acid methyl ester was prepared by
the literature procedure [36], by ozonolysis of 1-methoxycyclo-
heptene,  and  then  condensed  with  the  amidoalcohol  1  with
azeotropic removal of water to give the N,O-acetal 2 in 71%
yield as a single diastereoisomer. It is likely that allylic strain
of the lactam carbonyl group leads to the alkyl group preferen-
tially occupying a pseudo-axial position [37-40]. Reaction of
N,O-acetal  2  with  trimethylallyl  silane  and  titanium  tetra-
chloride at room temperature for two days gave the product 3
in  68%  yield.  The  alternate  diastereoisomer  could  not  be
detected by NMR spectroscopy in the crude reaction mixture.
Product 3 formally arises by attack of trimethylallyl silane from
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Figure 2: EIMS spectra of a) natural 5,9E-259B, b) synthetic 7, and c) synthetic minor diastereomer of 7. Structures are shown with relative configur-
ation.
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Figure 3: Vapor-phase FTIR spectra of a) natural 5,9E-259B, and b) synthetic 7. Structure shown with relative configuration.
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the least hindered face of the thermodynamically less stable
Z-iminium ion and the mechanistic details of this intriguing
transformation will be published elsewhere in due course. One-
pot dehydration of the tertiary alcohol 3 was accomplished via
the mesylate, and in situ elimination with triethylamine to give
the diene 4 in 74% yield. Diene 4 smoothly underwent cyclisa-
tion to indolizidinone 5 when treated with Grubbs' first genera-
tion  catalyst  [41,42].  Analysis  of  the  spectral  properties  of
indolizidine 5 was considered convenient to confirm the stereo-
chemistry at  C5.  It  is  known that  in indolizidinones,  with a
carbonyl group at C3, the C5 hydrogen in the equatorial posi-
tion will have an anomalously high chemical shift in NMR due
to it lying in the deshielding cone of the lactam carbonyl group
[5,37,38,43,44].  In  the  present  case,  the  proton at  C5 has  a
chemical shift at δ 4.24 ppm and the corresponding proton in
similar indolizidinones with the 5,9Z relative configuration has
a chemical shift at about δ 3.27 ppm. Reduction of the alkene 5
with hydrogen and a heterogeneous catalyst gave the product
indolizidines as a mixture of C8 diastereoisomers. When plat-
inum oxide was used as catalyst, a 1:1 mixture of diastereoi-
somers resulted, but when platinum-on-carbon was employed,
a 4:1 mixture was produced with the isomer corresponding to 6
(Scheme 1) predominating. We have previously shown [45],
and there is also good literature precedent [46,47], that in indol-
izidines with unsaturation at C7-C8 there is a tendency for the
addition reactions to occur on the concave face, although this
obviously will be influenced by the presence of other substitu-
ents. In the present case, there is an additional axial substituent
at C5, which again would encourage reaction from the concave
face. Although the mixture of isomers proved inseparable at
this stage, the relative configuration at C8 in both diastereoi-
somers could be readily assigned by examining the multiplets
for the hydrogen at C9. For the major diastereoisomer the coup-
ling constant J8-9 was 9.9 Hz, indicating a trans diaxial arrange-
ment of these hydrogens and for the minor diastereoisomer the
corresponding  J  value  was  3.9  Hz.  All  that  remained  to
complete  the  synthesis  was  the  reduction  of  the  lactam
carbonyl group and the installation of the cis-enyne function-
ality. Simultaneous reduction of both the ester and the amide
gave the alcohol 6. Dess Martin oxidation [48] of the alcohol 6
gave an aldehyde, which on Stork Zhao reaction [49] gave the
Z-vinyl iodide with a selectivity of 97:3. Finally, Sonogashira
reaction [50] of the vinyl iodide with trimethylsilylacetylene
followed by removal of the trimethylsilyl group gave synthetic
7. At this stage the C8 diastereoisomers were separated by flash
chromatography, though the minor component was contamin-
ated with triphenyl phosphine / phosphine oxide residue from
the Sonogashira reaction.
The  two  synthetic  C8  diastereoisomers  were  compared  to
natural  5,9E-259B  present  in  the  alkaloid  fraction obtained
from a bufonid toad, Melanophryniscus stelzneri [51]. The GC
mass spectra of the three compounds were very similar (Figure
2). However there was a greater loss of methyl for the natural
alkaloid. The GC FTIR spectrum of the major synthetic diaste-
reoisomer 7 differed from the natural 5,9E-259B in the finger-
print region (Figure 3). In addition, the vinyl C-H stretching
absorption band is at 3020 cm−1 rather than the expected 3032-
3038 cm−1 for a conjugated CH=CH, as found in synthetic 7
and in the minor diastereomer. Finally, the intense C-H absorp-
tion band at 2963 cm−1 in natural 5,9E-259B suggests that two
methyls rather than one are present. The corresponding band at
2961 cm−1  is merely a shoulder in the synthetic compounds
that contain only one methyl. The GC FTIR spectrum of the
minor synthetic isomer was very similar to that of the major
isomer 7, but due to a co-emerging contaminant the finger-print
region  could  not  be  compared  and  the  mixed  FTIR  is  not
shown. Remarkably, the GC retention time of the natural 5,9E-
259B  was markedly shorter  than those of  the  two synthetic
compounds as follows: Natural 5,9E-259B: 11.01 min; major
synthetic isomer 7: 13.01 min; minor synthetic isomer: 13.07
min. These retention times have been slightly adjusted to make
them consistent with the retention times reported for the many
frog skin alkaloids [2]. After hydrogenation the GC-retention
times of the products (MW 265) were changed only slightly
with the retention time of the perhydro-derivative of natural
5,9E-259B  still  markedly  less  than  those  of  the  perhydro-
synthetics. This result proves that the carbon skeleton of 259B
is different to 7 and supports the proposal that there is a branch
point in the C5 side-chain.
Clearly, a structural revision for 5,9E-259B  is needed and it
appears most likely that the point of difference is branching on
the C5 side-chain. Isolation of 5,9E-259B  for NMR spectral
analysis will be required to establish the presence and nature of
such branching. This hypothesis, if verified, is very significant
because branching of the side-chains of 'izidine' alkaloids has
been considered unlikely.  The only documented case  is  the
5,6,8-trisubstituted indolizidine 5,9E-249F, isolated for NMR
analysis from a dendrobatid frog, Dendrobates auratus, where
there  is  an  ethyl  branch in  the  C5 substituent  [51].  Further
study will be needed to determine what other izidines detected
in frog skin extracts have branch points in their side-chains.
See Supporting Information File 1 for full experimental data.
Conclusion
An extremely short entry to the unusual 5,8-disubstituted 5,9E-
indolizidine alkaloids has been developed giving a synthetic
sample of two possible structures corresponding to the struc-
ture  postulated  for  indolizidine  alkaloid  5,9E-259B.  The
synthetic compounds had mass and FTIR spectra similar, but
not identical to those of the natural product, but the GC-reten-
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tion times of the two synthetic C8 diastereomers, which were
quite similar, differed markedly from that of the natural 5,9E-
259B. Thus, the postulated structure of 259B is not correct and
further study will be required, in particular as to whether and
where the side-chain at C5 is branched.
Supporting Information
Supporting Information File 1
Experimental. Details of experimental procedures and data
for characterisation of new compounds.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-4-6-S1.doc]
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